Spondylitis
18
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (18)
Proprio Spine Measurement Tool
Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery
Evaluation of Outcomes of Surgical Treatment for Nonspecific Infectious Spondylodiscitis Via Posterior Approach in One Center.
Gene Expression Profiles in Spinal Tuberculosis.
Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis
Fecal Microbiota Transplantation in Axial Spondyloarthritis
The Living With a Long-Term Condition Study
Biologic National Registry
Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis
Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Burst Biologics Spinal Fusion Registry
Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study
Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis
Genetics of Ankylosing Spondylitis